NANEXA.ST Gross Margin

As of 2025-07-14, the Gross Margin of Nanexa AB (NANEXA.ST) is 107.1%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

NANEXA.ST Gross Margin - Historical Value

Date	Value
2024-12-31	107.1%
2023-12-31	117.5%
2022-12-31	-57.5%
2021-12-31	759.9%
2020-12-31	880.2%
2019-12-31	510.5%
2018-12-31	1296.9%
	-
	-
	-

NANEXA.ST Gross Margin - Peers Comparison

Ticker	Name	Value
ACARIX.ST	Acarix AB	90.2%
ALBLU.PA	Bluelinea SA	99.3%
ALCAR.PA	Carmat SA	-338.5%
ALICR.PA	ICeram SA	53.8%
ALIMP.PA	Implanet SA	53.1%
ALSAF.PA	Safe SA	74.4%
ALSGD.PA	Spineguard SA	70.8%
ALSPW.PA	Spineway SA	70.7%
ALTER.PA	Theradiag SA	74.2%
ALTHE.PA	Theraclion SA	42.9%
ALVMG.PA	Klea Holding	94.2%
ARCOMA.ST	Arcoma AB	39.9%
ARJO B.ST	Arjo AB (publ)	43.5%
AWM.WA	Airway Medix SA	-50%
BIOBV.HE	Biohit Oyj	65.3%
CEVI.ST	CellaVision AB	67.4%
CRAD B.ST	C Rad AB	47%
DEMG.L	Deltex Medical Group PLC	63.3%
DIGN.ST	Dignitana AB	67.1%
EKTA B.ST	Elekta AB (publ)	37.8%
ELOS B.ST	Elos Medtech AB	34.9%
GETI B.ST	Getinge AB	47.3%
GPXMED.ST	Neola Medical AB	1448.3%
HANDI.ST	Handicare Group AB	56%
IGPH.SW	IGEA Pharma NV	-22.2%
IMMNOV.ST	Immunovia AB (publ)	-6927.8%
IRRAS.ST	Irras AB	20.9%
IST.WA	Grupa Modne Zakupy SA	-824.2%
MKEA.PA	Mauna Kea Technologies SAS	9.8%
NSCI.L	Netscientific PLC	84.8%
NXTMH.HE	Nexstim Oyj	95.9%
PHLOG B.ST	Pharmacolog I Uppsala AB (publ)	65.7%
PLUN.ST	ProstaLund AB	64.6%
QLINEA.ST	Q linea AB	-470.5%
SCIB.ST	SciBase Holding AB (publ)	71%
SDOS.ST	ScandiDos AB	46.4%
STNT.PA	Stentys SA	40.6%
SUS.ST	Surgical Science Sweden AB	67.6%